Teladoc Health just gave shareholders a brutal reminder that cheap can always get cheaper. The stock closed at US$9.18 before the report and is now marked around US$6.58, a slide of more than 28% that wipes out the recent 7 day and 30 day bounce attempts. Yet the headline from the quarter is not a collapse in the core virtual care engine. The story is a pressure point in BetterHelp, where falling cash pay revenue and a thin margin are colliding with a long term bet on insurance based growth.

Is Teladoc Health at a rare value point after this selloff, or is the low P/S ratio just a warning sign in disguise? Compare the current price against our detailed valuation analysis for Teladoc Health.

Q2 2026 Earnings Summary

• Revenue (Q2 2026 vs Q2 2025): US$606.9 million vs. US$631.9 million (revenue declined 3.9%)
• Net Income or Loss (Q2 2026 vs Q2 2025): Net loss of US$38.9 million vs. net loss of US$32.7 million (loss widened 19.1%)
• Basic EPS (Q2 2026 vs Q2 2025): Loss of US$0.21 per share vs. loss of US$0.19 per share (loss per share increased 15.8%)
• Adjusted EBITDA Margin (Q2 2026 vs guidance reference): Adjusted EBITDA of US$66 million on US$607 million revenue, margin 10.8% (in line with management guidance commentary)

Prefer clean, visual charts instead of scrolling through another dense earnings release from Teladoc Health? Get a full picture of how the business is evolving with an easy to scan view of its revenue and profit trends in the latest company report for Teladoc Health.

Evaluating Teladoc’s Bull Case On BetterHelp And Integration

Bulls argue Teladoc Health can turn flat sales into a healthier model by shifting BetterHelp to insurance and leaning on Integrated Care and AI tools. The latest quarter gives mixed evidence. Integrated Care is broadly doing what the thesis needs. Revenue of US$394m with 100.3m covered lives and chronic care enrollment up 14% shows the membership base and multi condition platform are at least holding their ground while margins in this segment improved.

BetterHelp is where the hypothesis is being stress tested. Insurance revenue of US$22m and an implied annualized insurance run rate above US$110m, plus more than 8,000 credentialed providers and over US$150m contracted in network lives, show the insurance buildout is real. However, an 11.6% revenue decline and near breakeven EBITDA at BetterHelp confirm the transition is coming with meaningful near term revenue and margin friction.

Compare Teladoc Health’s internal progress on Integrated Care and BetterHelp with how Wall Street is reacting to the post earnings slide. See the consensus price target analysis for Teladoc Health to check whether analyst targets are catching down to the stock or still pricing in a rebound.

Teladoc Bear Case Gains Ground On BetterHelp Reset

The core worry around Teladoc Health is that margin pressure and weaker monetization will outweigh any scale benefits. Q2 gives that view more fuel than relief. Total revenue fell 3.9% to US$606.9m while the net loss widened to US$38.9m. However, the headline issue is BetterHelp. Revenue there declined 11.6% to US$213m and average paying users fell 11%, matching concerns that a shift away from cash pay would hurt growth and unit economics.

Bears also questioned whether insurance would simply replace higher margin subscription dollars with thinner, less predictable revenue. Insurance revenue reached US$22m, but BetterHelp’s adjusted EBITDA margin came in at only 0.2% and full year revenue for the segment is now guided to decline 12.7% to 19.0%. Integrated Care margins improved, which works against the most aggressive bear scenarios. Even so, the BetterHelp reset and lower consolidated revenue guidance show several key milestones were missed.

After a reset this sharp, it is fair to ask if BetterHelp’s margin strain and Teladoc Health’s wider losses are early signals of deeper structural issues. Review our independent risk analysis for Teladoc Health which shows 2 important warning signs to see if these concerns are isolated or part of a broader risk pattern already flagged.

Stay Ahead Of Your Next Move

If Teladoc Health’s BetterHelp reset and post earnings slide have you watching for a cleaner entry point, register for free with Simply Wall St and add it to your Watchlist to track price against fair value and key business metrics. Once you decide to take a position, keep your decisions grounded with the Portfolio Command Center that cuts through noise and surfaces only the most important updates on your holdings. For longer term conviction and fresh angles, use the Community to see what other investors are focusing on and how they interpret the same numbers. This way you can spot hidden catalysts or early warning signs sooner and stay ahead of the wider market.

Seeking Alternatives Beyond Teladoc Health?

Fresh stock ideas can move from quiet to flying once momentum builds, and the best entries often get caught early under the radar for now. Do not delay, act now.

• Spot cash generative opportunities that still look overlooked and scan a curated set of resilient companies using the 56 high quality undervalued stocks.
• Ride structural demand in critical materials and review a focused group of producers through the 8 top copper producer stocks while they remain under heavier screens of larger investors.
• Position ahead of potential infrastructure and policy catalysts and sift through a refined universe of nuclear related operators with the 90 nuclear energy infrastructure stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.